阿达木单抗-adalimumab
注释ID
1448995927
变量_单倍型
rs33980500
基因
TRAF3IP2
药物名称(英)
adalimumab
药物名称(中)
阿达木单抗
PMID
28107378
类型
Efficacy
含义
no
记事
At six months after beginning treatment, a significant association between rs33980500 and decreased response to TNF inhibitors (i.e. etanercapt and adalimumab) in terms of the number of patients in remission (p=0.02, OR=0.09, C.I.=0.01-0.70) or with low disease activity (p=0.013, OR=0.1, C.I.=0.02-0.87) was seen across the whole cohort, but was not seen at two years after beginning treatment and could not be replicated in the subgroups for each individual drug.
专家论述
Allele T is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.
等位基因
T
专家评论
备注
变体注释摘要
id研究类型特征类型
26100 cohort, retrospective Study Cohort
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3